Evidence map›Paper›PMID 8726968›Full record

ArticleNeurochemical research1996

Effects of brain ischemia on intermediate filaments of rat hippocampus.

M Camargo-De-Morais, M De Freitas, A G De Mattos, N Schröder, A C Zilles, C S Lisboa, N Arteni, A Barlem, R Schierholt, G Zwetsch and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

M Camargo-De-MoraisDepartamento de Bioquímica, IB--UFRGS (Campus Central), Porto Alegre, RS, Brazil.
M De Freitas
A G De Mattos
N Schröder
A C Zilles
C S Lisboa
N Arteni
A Barlem
R Schierholt
G Zwetsch
C A Souza
R Pessoa-Pureur
C A Netto
Universidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofilaments subunits (NF-H, NF-M, NF-L) and glial fibrillary acidic protein (GFAP) were investigated in the hippocampus of rats after distinct periods of reperfusion (1 to 15 days) following 20 min of transient global forebrain ischemia in the rat. In vitro [14Ca]leucine incorporation was not altered until 48 h after the ischemic insult, however concentration of intermediate filament subunits significantly decreased in this period. Three days after the insult, leucine incorporation significantly increased while the concentration NF-H, NF-M, and NF-L were still diminished after 15 days of reperfusion. In vitro incorporation of 32P into NF-M and NF-L suffered immediately after ischemia, but returned to control values after two days of reperfusion. GFAP levels decreased immediately after ischemia but quickly recovered and significantly peaked from 7 to 10 days after the insult. These results suggest that transient ischemia followed by reperfusion causes proteolysis of intermediate filaments in the hippocampus, and the proteolysis could be facilitated by diminished phosphorylation levels of NF-M and NF-L.

Indexed as

AnimalsCarbon RadioisotopesCytoskeletal ProteinsGlial Fibrillary Acidic ProteinHippocampusIschemic Attack, TransientKineticsLeucineNeurofilament ProteinsPhosphorus RadioisotopesRadioisotope Dilution TechniqueRatsRats, WistarReperfusionTime FactorsCarbon RadioisotopesCytoskeletal ProteinsGlial Fibrillary Acidic ProteinLeucineneurofilament protein Hneurofilament protein Lneurofilament protein MNeurofilament ProteinsPhosphorus Radioisotopes

Identifiers

PMID8726968
OpenAlexW1990315931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.